Concepedia

Author

Max Roessler

University of Bonn

Also Known As

M ROESSLER, M Roessler, M. Roessler, MAX ROESSLER, Max Roessler

23

Publications

421

Citations

8

H-Index

41

Concepts

All Affiliations

University of BonnLeiden University Medical CenterCentral European Society for Anticancer Drug ResearchSaladax Biomedical (United States)Essen University Hospital
MR

About

Max Roessler is an author at University of Bonn specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

201

2

Pharmacology

3

3

181

3

Engineering

1

1

12

4

Obstetrics

1

1

20

5

Pathology

1

1

20

Max Roessler

×

8

Publications

392

Citations

8

H-Index

YearCitations

Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer

Peter Horak, Dietmar Pils, Griet Haller,

Molecular Cancer Research

2005

148

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)

Markus Joerger, Joachim von Pawel, Stefanie Kraff,

Annals of Oncology

2016

85

Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice

Martin Wilhelm, Lothar Mueller, Michael Craig Miller,

Clinical Colorectal Cancer

2016

65

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

Achim Fritsch, Friederike Kanefendt, JJ Swen,

CPT Pharmacometrics & Systems Pharmacology

2017

31

Common death receptor 4 (DR4) polymorphisms do not predispose to ovarian cancer

Peter Horak, Dietmar Pils, Max Roessler,

Gynecologic Oncology

2005

20

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity

Loes F.M. van der Zanden, Sita H. Vermeulen, Arna Óskarsdóttir,

Urologic Oncology Seminars and Original Investigations

2017

19

Optimal aerodynamic-propulsive maneuvering for the orbital plane change of a space vehicle.

Max Roessler

Journal of Spacecraft and Rockets

1967

12

A Genetic Polymorphism in <i>CTLA-4</i> Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

Xiaoyan Liu, Jesse J. Swen, Meta H.M. Diekstra,

Clinical Cancer Research

2018

12

Page 1